TX-MAVENIR
6.12.2023 16:20:38 CET | Business Wire | Press release
Pardeep Kohli, CEO of Mavenir, the Network Software Provider building the future of networks with cloud-native solutions that run on any cloud, has today welcomed the new ranking by global technology intelligence company ABI Research that recognizes Mavenir as the leading vendor in Open Radio Access Network (Open RAN) solutions. In ABI Research’s detailed and independent Competitive Assessment vendor matrix, Mavenir tops all three ranking categories – market leadership, innovation and implementation.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20231206233989/en/
ABI Research Open RAN Vendor Ranking November 2023 (Graphic: Business Wire)
Mavenir is classed as the leading innovator in the Open RAN space with an impressive score of 81.5 out of 100, while its achievement of 84.5 out of 100 in the implementation criteria reflects Mavenir’s central role in accelerating Open RAN deployments globally. These key rankings position Mavenir as the overall global market leader for Open RAN in the ABI Research assessment framework.
Commenting on Mavenir’s stand-out performance in the global vendor analysis, Mavenir CEO Pardeep Kohli said: “I wholeheartedly welcome this recognition of our market leadership by ABI Research, following a robust and impartial assessment of both new and incumbent players. This pole-position ranking – delivered through ABI Research’s respected and transparent process – is a significant endorsement of our dedicated mission to create the market conditions, forge the industry partnerships and deliver the technology innovation to accelerate ubiquitous and large-scale Open RAN deployments, generating powerful gains for operators and users alike.”
Using a rigorous and thorough assessment framework, ABI Research has evaluated the leading Open RAN vendors to provide a comprehensive and authoritative picture of the competitive dynamics of the Open RAN vendor ecosystem. The core areas of analysis span ten criteria, segmented across innovation and implementation clusters – including R&D activities, O-RAN Alliance contributions, support for mMIMO, recent commercial momentum, product portfolio, geographical coverage, partnerships and memberships, PoCs/trials/testing, energy efficiency commitments and brownfield deployments – concluding with an in-depth profile of the implementation and innovation strategies of the major market players.
Saqlain Ali, Senior Analyst at ABI Research remarked: “Mavenir ranked overall leader in the competitor ranking and earned the top spots for both innovation and implementation. Mavenir has demonstrated its role as a leading Open RAN vendor due to its end-to-end cloud-native software and hardware and O-RAN Alliance-compliant solutions.”
He added: “Mavenir has made significant efforts to accelerate Open RAN deployments in partnerships with other mobile, chipset vendors, and cloud providers to validate its Open RAN portfolio for multi-vendor deployments. Mavenir’s customer base is diverse, with Mavenir serving 300+ CSPs in more than 120 countries.”
The report authors highlight several areas where Mavenir is demonstrating its role as a leading industry innovator in the Open RAN domain, including its provision of end-to-end cloud-native software and hardware solutions with a comprehensive portfolio covering the core, edge and Open RAN. Further emphasized in the framework are Mavenir’s open and fully virtualized RAN (vRAN), its O-RAN Alliance-compliant solution designed to support Open RAN Functional Split (FS) options, plus Mavenir’s OpenBeam™ mMIMO portfolio, which supports both the 3rd Generation Partnership Project (3GPP) and O-RAN Alliance-compliant radios.
Mavenir’s clear commercial momentum during 2023 is a key factor in its top-ranking performance, including its announcement of multiple successful trials and new strategic partnerships with CSPs, cloud providers, and chipset vendors. The assessors particularly note the expansion of Mavenir’s geographical coverage in supporting major mobile operators with Open RAN deployment. Finally, the report draws attention to the considerable breadth of Mavenir’s partner ecosystem, plus its active collaboration with cloud providers, chipset vendors, mobile vendors, and operators to perform Open RAN integration and interoperability testing.
Notes to editors:
- ABI Research, Open RAN Vendor Assessment: Mavenir
© 2023 ABI Research. Distributed with permission of ABI Research. ABI Research Competitive Ranking, Open RAN Portfolio: November 2023
About ABI Research:
ABI Research is a global technology intelligence firm delivering actionable research and strategic guidance to technology leaders, innovators, and decision makers around the world. Our research focuses on the transformative technologies that are dramatically reshaping industries, economies, and workforces today.
For more information about ABI Research’s services, contact us at +1.516.624.2500 in the Americas, +44.203.326.0140 in Europe, +65.6592.0290 in Asia-Pacific, or visit www.abiresearch.com.
About Mavenir:
Mavenir is building the future of networks and pioneering advanced technology, focusing on the vision of a single, software-based automated network that runs on any cloud. As the industry's only end-to-end, cloud-native network software provider, Mavenir is focused on transforming the way the world connects, accelerating software network transformation for 250+ Communications Service Providers and Enterprises in over 120 countries, which serve more than 50% of the world’s subscribers. www.mavenir.com
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20231206233989/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Align Partners Issues Public Shareholder Letter and Submits Formal Shareholder Proposals to DB Insurance9.2.2026 15:26:00 CET | Press release
Align Partners underscores DBI’s persistent undervaluation (0.40x Adjusted PBR), despite industry-leading profitability, identifying inefficient capital allocation and governance issues as primary driversAlign Partners outlines measures for capital efficiency and governance normalization; requests a revised “Value-up” plan and a formal response from the Board by March 6, 2026The proposals nominate two Independent Directors via separate election and calls for the reinstatement of the Internal Transaction Committee Align Partners Capital Management Inc. (“Align Partners”), a shareholder of DB Insurance Co., Ltd. (KRX:005830) (“DBI” or the “Company”) holding 1.9%, has issued a public shareholder letter to DBI’s Board of Directors aimed at strengthening capital allocation policy and governance oversight, and submitted formal shareholder proposals for the 2026 Annual General Meeting (“AGM”). Despite DBI’s robust fundamentals—including a 16.1% ROE and a 226% K-ICS ratio—the Company trades at
Promega Unveils Cellular Target Engagement Technology Aimed at Expanding the Druggable Proteome at SLAS 20269.2.2026 13:00:00 CET | Press release
TarSeer™ BRETSA™ Target Engagement System enables studies for difficult proteins early in drug discovery Promega Corporation is launching a new live-cell target engagement platform that could close a long-standing gap between biochemical and cellular assays for understudied or difficult-to-interrogate proteins. The TarSeer™ BRETSA™ Target Engagement System is a novel bioluminescence resonance energy transfer-based shift assay for detecting ligand-protein interactions in intact cells using protein denaturation. It gives drug discovery researchers early, target-specific cellular insights by validating weak or early chemical matter and expanding the targets accessible in live-cell drug discovery workflows. The technology will be debuted at the Society for Laboratory Automation and Screening (SLAS) International Conference and Exhibition in Boston, February 7-11, 2026. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260206015371/
Eurofins Viracor BioPharma Expands Bioanalytical Capabilities9.2.2026 13:00:00 CET | Press release
Eurofins Viracor BioPharma Services, a long‑standing and trusted partner for clinical trial testing solutions with deep expertise in specialty biomarkers and molecular assays, announces a significant expansion of its service portfolio with the addition of enhanced bioanalytical testing capabilities. These new services are fully aligned with Good Laboratory Practices (GLP) and Good Clinical Practices (GCP), enabling the company to enhance support of biopharmaceutical development programs with greater scientific breadth throughout the drug development workflow. This strategic advancement follows the successful relocation and integration of Eurofins Pharma Bioanalytics Services from St. Charles, Missouri, into Eurofins Viracor BioPharma’s purpose‑built, eleven‑acre facility in Lenexa, Kansas. The bioanalytical organization brings more than two decades of specialized experience in pharmacokinetics, immunogenicity, and biomarker testing. By combining both laboratories’ strengths, Eurofins V
HKTDC to Host World’s Largest One-Stop Jewellery Marketplace9.2.2026 11:37:00 CET | Press release
New Hard Pure Gold Pavilion showcases breakthrough gold technologies Organised by the Hong Kong Trade Development Council (HKTDC), the world’s largest one‑stop jewellery marketplace will return in early March under its proven “Two Shows, Two Venues” format. The 12th Hong Kong International Diamond, Gem & Pearl Show will take place from 2 to 6 March at AsiaWorld‑Expo, featuring a wide range of jewellery raw materials. Also, the 42nd Hong Kong International Jewellery Show will be held from 4 to 8 March at the Hong Kong Convention and Exhibition Centre, showcasing finished jewellery pieces. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260207153040/en/ Hong Kong International Jewellery Show and Hong Kong International Diamond, Gem & Pearl Show Jenny Koo, Deputy Executive Director of the HKTDC, said: “This year’s twin jewellery shows bring together some 4,000 exhibitors from over 40 countries and regions, with nearly 70% coming
FlexTrade Integrates CME Group’s FX Spot+ and EBS Market Offerings for Enhanced FX Trading9.2.2026 11:30:00 CET | Press release
The initiative will see FlexTrade FX clients seamlessly access CME Group’s primary FX markets within FlexFX. FlexTrade Systems(@FlexTrade), a global leader in multi-asset execution and order management systems, today announced an integration with CME Group’s EBS Market central limit order book (CLOB) and its FX Spot+ platform.The move is designed to diversify and deepen the sources of actionable liquidity available to FlexTrade’s FlexFX users through an integration into CME Group's substantial liquidity pools for spots via FX Spot+. Providing firm, anonymous liquidity and no last-look pricing, EBS Market is a venue for both large market participants in search of FX liquidity in an all-to-all CLOB, and for market-making banks hedging FX risk. FX Spot+ further enhances spot liquidity with Futures liquidity from CME Group. This partnership is integral in helping firms further expand FX liquidity and take advantage of global opportunity. Mutual clients of FlexTrade and CME Group can integr
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom